Notice Information: - 3rd Party Publications - 23/12/2011
European Medicines Agency announces a review of aliskiren-containing medicines
Rasilamlo, Rasilez, Rasilez HCT, Rasitrio, Riprazo, Riprazo HCT, Sprimeo, Sprimeo HCT
The European Medicines Agency has started a review of aliskiren-containing medicines following termination of ALTITUDE study and has provided interim advice while review is ongoing.
European Medicines Agency - press release